Abstract
Background:
Neurological involvement occurs in 10 to 28% of patients with Behçet's disease.
Case report:
We report a case of neurological pseudotumoral presentation of Behçet's in a patient with a long standing disease treated with low dose of prednisone and colchicine (1 mg/day), 2 months after withdrawal of colchicine.
Conclusion:
Neurological manifestations during Behçet disease can be secondary to direct central nervous system involvement (encephalitis, encephalomyelitis) or vascular angitis (essentially cerebral venous thrombosis and, rarely, intracranial aneurysms). Neurological pseudotumoral presentation is rarely reported.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / therapeutic use
-
Behcet Syndrome / diagnosis*
-
Behcet Syndrome / drug therapy
-
Brain Diseases / chemically induced*
-
Brain Diseases / diagnosis
-
Colchicine / administration & dosage
-
Colchicine / adverse effects*
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use
-
Female
-
Follow-Up Studies
-
Gout Suppressants / adverse effects*
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use
-
Magnetic Resonance Imaging
-
Middle Aged
-
Prednisone / administration & dosage
-
Prednisone / therapeutic use
-
Substance Withdrawal Syndrome*
-
Time Factors
Substances
-
Anti-Inflammatory Agents
-
Gout Suppressants
-
Immunosuppressive Agents
-
Cyclophosphamide
-
Colchicine
-
Prednisone